Marketwatch No Chinese supply threat for drug companies, but scaling Great Wall is tough Admin June 3, 2020 “The concerns over supply of Chinese raw material proved to be ill-founded,” Nilesh Gupta, managing director of Lupin, told ET. – Stocks-Markets-Economic Times Share on Facebook Tweet it Pin it Share it Email
